For the 89,000 patients with cystic fibrosis worldwide, mucolytics, anti-inflammatories, and antibiotics should be used for first-line pulmonary treatments, authors of a review article conclude,
In a technical report from the American Academy of Pediatrics, an expert panel provides recommendations for providing medications to pediatric patients at the point of
At 25 tertiary neonatal intensive care units (NICUs) in China, preterm infants without infections had higher risks of bronchopulmonary dysplasia (BPD) and late antibiotic use
The authors of a Viewpoint article believe an American Academy of Pediatrics (AAP) clinical practice guideline for the evaluation and treatment of children with obesity
In English primary care practices, a multifaceted antibiotic stewardship intervention was not effective for improving prescribing patterns or outcomes in children aged 0 to 9
Blinatumomab, a bispecific T-cell engager molecule targeting CD19, was safe and had a high level of efficacy in infants with newly diagnosed KMT2A-rearranged acute lymphoblastic leukemia
Opioids are an increasingly common cause of fatal poisoning among children ages 5 years or younger, followed by nonprescription pain, cold, and allergy products, according
In the 9 influenza seasons after the 2009 A(H1N1) pandemic, vaccinations provided “substantial benefit against outpatient illness,” according to a CDC study, with vaccine effectiveness
Encouraging effectiveness results and lack of adverse events with tocilizumab and remdesivir in premature twins with COVID-19 “have important implications for their potential expanded use
Compared with placebo, verapamil partially preserved stimulated C-peptide secretion among children and adolescents with newly diagnosed type 1 diabetes at 52 weeks, a study shows.